{"id":25143,"date":"2025-11-24T08:15:04","date_gmt":"2025-11-24T06:15:04","guid":{"rendered":"https:\/\/ibsal.es\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/"},"modified":"2025-11-24T08:15:04","modified_gmt":"2025-11-24T06:15:04","slug":"partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2","status":"publish","type":"tribe_events","link":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/","title":{"rendered":"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR)"},"content":{"rendered":"<h3 style=\"color: #003c8c;\">Features<\/h3>\n<p>The first joint transnational call for proposals from the  <a href=\"https:\/\/ohamr.eu\/\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/ohamr.eu\/&#038;source=gmail&#038;ust=1764057575368000&#038;usg=AOvVaw19VTuuRhbBc1Xkq4iFGCq9\"><b>EUP OHAMR<\/b> Partnership on Antimicrobial Resistance,<\/a>  titled  <b>&#8220;Treatments and Adherence to Treatment Protocols&#8221;<\/b><\/p>\n<p>The goal of this call for proposals is to improve treatment success rates in patients, animals, and plants affected by bacterial or fungal infections by offering new treatment options while reducing the risk of resistance development across the various settings of <b>the \u201cOne Health\u201d<\/b> approach <b>.<\/b><\/p>\n<p style=\"font-weight: 400;\">The call for proposals is co-financed by the European Union and involves 37 funding organizations from 28 countries, with a total estimated budget of more than 31 million euros.<\/p>\n<p style=\"font-weight: 400;\">In addition, the following national and regional funding agencies are participating in this call <strong>for proposals<\/strong>: the <strong>Aragon Institute of Health Sciences (IACS)<\/strong>, the <strong>State Research Agency (AEI)<\/strong>, and the <strong>Carlos III Health Institute (ISCIII)<\/strong>.<\/p>\n<h3 style=\"color: #003c8c;\">Requirements<\/h3>\n<p>Proposals must address one of the following topics:<\/p>\n<p><a href=\"https:\/\/ohamr.eu\/calls\/call-2026-new-treatments-to-tackle-amr\/#call-topics-15a780\">Topic 1:<\/a> Identify and develop new combination therapies using existing or innovative antimicrobials, or antimicrobials in combination with adjunctive therapies, to extend drug efficacy and combat resistance.<\/p>\n<p><a href=\"https:\/\/ohamr.eu\/calls\/call-2026-new-treatments-to-tackle-amr\/#call-topics-15a780\">Topic 2:  Develop <\/a> tools and methods to improve adherence to treatment protocols.<\/p>\n<p><a href=\"https:\/\/ohamr.eu\/calls\/call-2026-new-treatments-to-tackle-amr\/#call-topics-15a780\">Topic 3:<\/a> Assess the impact of antimicrobials used in veterinary and agricultural settings on the risk of AMR transmission to humans and the environment, to inform policies on restricting certain antimicrobials for human use.<\/p>\n<h3><\/h3>\n<h3 style=\"color: #003c8c;\">Submission deadline.<\/h3>\n<p>The following table lists the different dates:<\/p>\n<table border=\"0\" cellspacing=\"1\" cellpadding=\"8\" align=\"center\">\n<thead>\n<tr>\n<th scope=\"col\">Phase<\/th>\n<th scope=\"col\">Date<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Call Opens<\/td>\n<td>November 18, 2025<\/td>\n<\/tr>\n<tr>\n<td>Deadline for Pre-Proposals<\/td>\n<td>February 2, 2026, (1:00 p.m. CET)<\/td>\n<\/tr>\n<tr>\n<td>Notification of the Results of the Pre-Proposal<\/td>\n<td>April 29, 2026<\/td>\n<\/tr>\n<tr>\n<td>Deadline for full proposals<\/td>\n<td>June 17, 2026, (1:00 p.m. CET)<\/td>\n<\/tr>\n<tr>\n<td>Final Funding Recommendation Announced<\/td>\n<td>October 30, 2026<\/td>\n<\/tr>\n<tr>\n<td>Projects begin<\/td>\n<td>December 2026\u2013April 2027<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Features The first joint transnational call for proposals from the EUP OHAMR Partnership on Antimicrobial Resistance, titled &#8220;Treatments and Adherence to Treatment Protocols&#8221; The goal of this call for proposals [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":"","_members_access_role":[],"_members_access_error":"","_tec_slr_enabled":"","_tec_slr_layout":""},"tags":[],"tribe_events_cat":[256],"class_list":["post-25143","tribe_events","type-tribe_events","status-publish","hentry","tribe_events_cat-calls-for-research","cat_calls-for-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.12 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR) | IBSAL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR)\" \/>\n<meta property=\"og:description\" content=\"Features The first joint transnational call for proposals from the EUP OHAMR Partnership on Antimicrobial Resistance, titled &#8220;Treatments and Adherence to Treatment Protocols&#8221; The goal of this call for proposals [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/\" \/>\n<meta property=\"og:site_name\" content=\"IBSAL\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibsal.es\/wp-content\/uploads\/2024\/10\/Snippet.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\\\/\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\\\/\",\"name\":\"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR) | IBSAL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\"},\"datePublished\":\"2025-11-24T06:15:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/evento\\\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/institute-of-biomedical-research-of-salamanca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/eventss\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/\",\"name\":\"IBSAL\",\"description\":\"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n\",\"alternateName\":\"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibsal.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR) | IBSAL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/","og_locale":"en_US","og_type":"article","og_title":"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR)","og_description":"Features The first joint transnational call for proposals from the EUP OHAMR Partnership on Antimicrobial Resistance, titled &#8220;Treatments and Adherence to Treatment Protocols&#8221; The goal of this call for proposals [&hellip;]","og_url":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/","og_site_name":"IBSAL","og_image":[{"width":1200,"height":675,"url":"https:\/\/ibsal.es\/wp-content\/uploads\/2024\/10\/Snippet.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/","url":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/","name":"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR) | IBSAL","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/#website"},"datePublished":"2025-11-24T06:15:04+00:00","breadcrumb":{"@id":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibsal.es\/en\/evento\/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibsal.es\/en\/institute-of-biomedical-research-of-salamanca\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/ibsal.es\/en\/eventss\/"},{"@type":"ListItem","position":3,"name":"PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR)"}]},{"@type":"WebSite","@id":"https:\/\/ibsal.es\/en\/#website","url":"https:\/\/ibsal.es\/en\/","name":"IBSAL","description":"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n","alternateName":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibsal.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"ticketed":false,"_links":{"self":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/users\/16"}],"version-history":[{"count":0,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events\/25143\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media?parent=25143"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tags?post=25143"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tribe_events_cat?post=25143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}